Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

This publication has 25 references indexed in Scilit:

• A Phase III Randomized Study of Image Guided Conventional (60 Gy/30 fx) Versus Accelerated, Hypofractionated (60 Gy/15 fx) Radiation for Poor Performance Status Stage II and III NSCLC Patients—An Interim Analysis
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
• Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
• SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status
  European Journal of Cancer, 2014
• Image Guided Hypofractionated 3-Dimensional Radiation Therapy in Patients With Inoperable Advanced Stage Non-Small Cell Lung Cancer
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
• Methods for the guideline-based development of quality indicators--a systematic review
  Implementation Science, 2012
• Institute of Medicine's Forum on Medical and Public Health Preparedness for Catastrophic Events: Current Initiatives
  Disaster Medicine and Public Health Preparedness, 2010
• Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)
  European Journal of Cancer, 2007
• Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15)
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
• Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status
  Clinical Oncology, 1996
• A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status
  British Journal of Cancer, 1992